Skip to main content
. 2019 May 31;9(13):3768–3779. doi: 10.7150/thno.34327

Figure 6.

Figure 6

Proposed working model. Melatonin enhances sorafenib-induced cytotoxicity in FLT3-ITD acute myeloid leukemia cells by redox modification.